Benicia, CA, United States of America

Robert A Tenold

This inventor holds 2 USPTO granted patents. Top assignee: Cutter Laboratories, Inc.. Active years: 1983-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert A Tenold. Retrieved from https://idiyas.com/inventor/robert-a-tenold

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 2

Forward Citations = 105(Granted Patents)


Company Filing History:


Years Active: 1983-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert A. Tenold

Introduction

Robert A. Tenold is a notable inventor based in Benicia, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of immune serum globulin compositions. With a total of 2 patents to his name, Tenold's work has the potential to impact medical treatments significantly.

Latest Patents

Tenold's latest patents focus on an intravenously injectable immune serum globulin. The composition disclosed in these patents comprises a solution in a pharmaceutically acceptable carrier. This solution is designed to maintain the monomer content and the actual and latent anticomplement activity of the immune serum globulin. The innovative methods outlined for preparing this composition ensure that it is safe and effective for intravenous injection.

Career Highlights

Robert A. Tenold is associated with Cutter Laboratories, Inc., where he has been instrumental in advancing research and development in immunology. His expertise in creating formulations that enhance the efficacy of immune serum globulin showcases his commitment to improving patient care.

Conclusion

Robert A. Tenold's contributions to the field of pharmaceuticals through his patents on immune serum globulin compositions highlight his innovative spirit and dedication to medical advancements. His work continues to pave the way for new treatment options in immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…